Delivery Order SPE2DB22D1202-SPE2DB24FVKM8
Award Date
8/12/24
Potential Completion Date
8/13/24
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Telmisartan-Amlodipine 40-5 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $2,005.00. It has an ultimate completion date of July 31, 2024. This award is not associated with a set-aside program. AmerisourceBergen, the prime contractor, will be providing these essential...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,792.95 Firm Fixed Price delivery order is for the supply of Telmisartan-Amlodipine 40-5 mg tablets. The contract has an ultimate completion date of November 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan-Amlodipine 80-10 30s medication. The contract has a ceiling value of $2,323.32 and an ultimate completion date of July 31, 2024. The award is not associated with a set-aside program. Amerisourcebergen, through its Corporate Office division, has been a significant supplier of pharmaceutical products and medical...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The $2,172.72 firm fixed-price delivery order is for the supply of Telmisartan-Amlodipine 40-5 mg medication in 30-count packages. The contract has an ultimate completion date of May 31, 2024 and was awarded on May 30, 2024 without any set-aside designation....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,631.94, is a delivery order for the supply of Telmisartan-Amlodipine 40-5 mg tablets. The contract has an ultimate completion date of March 7, 2025 and is a firm fixed-price agreement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $2,648.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Telmisartan-Amlodipine 40-5 mg tablets, which are used to treat cardiovascular conditions. The contract has an ultimate completion date of March 3, 2025 and is a Firm Fixed Price agreement. AmerisourceBergen holds a significant Indefinite...
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,936.38 for the supply of Telmisartan-Amlodipine 40-5 mg medication. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 21, 2025. The contract type is Firm Fixed Price. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $4,584.33, was issued by the Medical Supply Chain division of the Defense agency to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Telmisartan-Amlodipine 80-10 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,775,064 units of the pharmaceutical product TELMISARTAN-AMLODIPINE 40-5 MG 30S. The contract has a completion date of February 27, 2024 and a potential value of $2,958.74. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which falls under a larger indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Telmisartan-Amlodipine 40-5 mg tablets. The contract has a ceiling value of $2,264.67 and a period of performance through April 3, 2025. It was awarded on April 2, 2025 as a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that provides medical products and prescription drugs to...